Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Oncol.

Sec. Gastrointestinal Cancers: Colorectal Cancer

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1613093

This article is part of the Research TopicRadiomics and AI-Driven Deep Learning for Cancer Diagnosis and TreatmentView all 13 articles

Predicting Early Recurrence of Colorectal Cancer Liver Metastases: An Integrative Approach Using Radiomics and Machine Learning

Provisionally accepted
Yanzong  LinYanzong Lin1Yunxia  HuangYunxia Huang2Zhaohui  LiuZhaohui Liu3Xiaobin  FengXiaobin Feng4*Chunkang  YangChunkang Yang1*
  • 1Department of Colorectal Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China
  • 2Department of Radiation Oncology, First Affiliated Hospital of Xiamen University, Xiamen, Fujian Province, China
  • 3Department of General Surgery, First Affiliated Hospital of Xiamen University, Xiamen, Fujian Province, China
  • 4Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, Institute for Precision Medicine, Key Laboratory of Digital Intelligence Hepatology (Ministry of Education), Tsinghua University,, Beijing, China

The final, formatted version of the article will be published soon.

Background: The overall incidence of liver metastasis in colorectal cancer is as high as 50%, and surgery remains the only potentially curative approach for the metastatic disease. The recurrence rate of liver metastases within one year after surgery is still 60%-70% in clinical practice. Whether we can accurately predict the early recurrence of patients after surgery is one of the most important considerations in formulating the overall treatment strategy. Methods: In this study, we combined radiomics feature extraction with machine learning classification methods to develop a novel strategy for predicting intrahepatic metastases based on imaging radiomics and machine learning. We constructed and systematically evaluated multiple machine learning models to assess their performance. By validating these models on a test set, we determined the effectiveness of each predictive model and selected the one with the highest predictive accuracy. Results: The integration of radiomics and machine learning methods demonstrated significant potential in predicting intrahepatic recurrence within one year after surgery in patients with colorectal cancer liver metastases. The Gradient Boosting, LightGBM, and Random Forest models all achieved classification accuracies (ACC) exceeding 65% across all classification tasks. Notably, the Random Forest model exhibited the best performance; while its classification accuracy was 65.52% in the imaging-only group, it increased to 75.86% when both imaging and clinical information were combined, with an area under the receiver operating characteristic curve (AUC) of 70.83%, indicating strong predictive capability. These findings suggest that these models have potential application value in supporting the diagnostic work of clinical radiologists, potentially helping to reduce workload and decrease the risk of misdiagnosis. Conclusions: The imaging omics model and the combined model have good predictive efficacy for the recurrence of colorectal cancer liver metastases within one year, and can be used to assist in the clinical stratification of postoperative patients and identify high-risk factors for poor prognosis.

Keywords: Colorectal liver metastasis, CT radiomics, machine learning, Intrahepatic recurrence, prediction

Received: 16 Apr 2025; Accepted: 29 Aug 2025.

Copyright: © 2025 Lin, Huang, Liu, Feng and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Xiaobin Feng, Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, Institute for Precision Medicine, Key Laboratory of Digital Intelligence Hepatology (Ministry of Education), Tsinghua University,, Beijing, China
Chunkang Yang, Department of Colorectal Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.